"Low Dose MR" Dixon Technique for Imaging FDG PET-MR Lymphoma

被引:1
|
作者
Mufti, Musa Ali [1 ]
Matthews, Robert [2 ]
Madu, Ezemonye [3 ]
Yaddanapudi, Kavitha [4 ]
Franceschi, Dinko [2 ]
机构
[1] Stonybrook Univ Hosp, Dept Radiol, New York, NY 11794 USA
[2] Stony Brook Univ Hosp, Dept Nucl Med, New York, NY USA
[3] Hofstra Northwell, Sch Med, New York, NY USA
[4] Coll Med, Dept Med Imaging, Tucson, AZ USA
关键词
Keywords; Dixon sequence; PET-MR; lymphoma; FDG; multi-sequence MR; RESPONSE ASSESSMENT; HODGKIN; PET/MRI;
D O I
10.1055/s-0042-1750330
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction Hybrid PET-MR is a relatively new imaging modality with its major strength being the MR component offering superior soft tissue contrast. While PET/MRI offers the inherent advantage of reduced radiation dose, it has been shown to result in a markedly prolonged examination time becoming a challenge in children and sick patients. "Low dose MRI" is a term used in the nuclear medicine community to describe fast acquired PET-MR scan protocols that rely heavily on PET images for diagnosis. In this study, we sought to determine if the Dixon sequences obtained for attenuation correction could be used as a diagnostic sequence for interpreting PET-MRI lymphoma cases, potentially reducing scan time. Materials and Methods We retrospectively identified 40 patients who underwent (88) FDG PET-MR body imaging studies for staging or restaging lymphoma. A radiologist and nuclear medicine physician initially reviewed top of the head to mid thigh PET images, attenuation correction coronal Dixon MRI sequences, and PET-MR fusion with Dixon sequence. The same physicians reviewed the PET images, multi-sequence MR including the attenuation correction Dixon, and multi-sequence PET-MR fusion images The lesions were further characterized based on their imaging characteristics, size, SUVmax, and malignant potency. A consensus read followed. Results All patients were adults with an average study age of 43.8 years. Our study consisted of 40 females and 48 males out of which 7 were for staging and 81 were for re-staging. All patients had systemic lymphoma. Thirty-seven of the studies had active lymph nodes on Dixon PET-MR that agreed with multi-sequence PET-MR which identified 33 positive cases (89.1%) having an average SUV 10.2 +/- 7.74 SD. Four Dixon PET-MR cases did not detect lesions, with an average SUV 2.3 +/- 0.55 SD, which was read as minimal residual activity. Multi-sequence MR identified 11 patients with enlarged lymph nodes without FDG uptake, which were not seen on Dixon MR. All 5 studies with bones lesions were detected by Dixon PET-MR as well as 2 soft tissue organ lesions. Multi-sequence MR identified 1 patient with non-active, healed bone lesion. Fifty-five of these studies were true negatives. Compared to multi-sequence PET-MR, Dixon PET-MR demonstrated 89.2% sensitivity, 100% specificity with no false positive studies. Conclusion The present study investigated the diagnostic potential of a fast protocol for integrated PET/MRI used for dedicated tumor staging of patients with lymphoma. In this retrospective study, Dixon PET-MR was shown to be sensitive and specific compared to multi-sequence PET-MR in the detection of lymphoma. The low number of these cases not detected had minimally active lymph nodes that resolved on subsequent imaging and probably were not clinically important.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 50 条
  • [21] MR-Based Cardiac and Respiratory Motion-Compensation Techniques for PET-MR Imaging
    Munoz, Camila
    Kolbitsch, Christoph
    Reader, Andrew J.
    Marsden, Paul
    Schaeffter, Tobias
    Prieto, Claudia
    PET CLINICS, 2016, 11 (02) : 179 - 191
  • [22] Hybrid Imaging (PET-Computed Tomography/PET-MR Imaging) of Bone Metastases
    Schmidkonz, Christian
    Ellmann, Stephan
    Ritt, Philipp
    Roemer, Frank W.
    Guermazi, Ali
    Uder, Michael
    Kuwert, Torsten
    Baeuerle, Tobias
    PET CLINICS, 2019, 14 (01) : 121 - +
  • [23] Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: 18F-FDG PET, MR Imaging, or 18F-FDG PET/MR Imaging?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    Nievelstein, Rutger A. J.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 2017 - 2018
  • [24] Clinical PET-MR Imaging in Breast Cancer and Lung Cancer
    Rice, Samuel L.
    Friedman, Kent P.
    PET CLINICS, 2016, 11 (04) : 387 - +
  • [25] The Use of Contrast Agents in Clinical and Preclinical PET-MR Imaging
    Sandiford, Lydia
    de Rosales, Rafael T. M.
    PET CLINICS, 2016, 11 (02) : 119 - +
  • [26] MR-based motion correction for PET imaging using wired active MR microcoils in simultaneous PET-MR: Phantom studya)
    Huang, Chuan
    Ackerman, Jerome L.
    Petibon, Yoann
    Brady, Thomas J.
    El Fakhri, Georges
    Ouyang, Jinsong
    MEDICAL PHYSICS, 2014, 41 (04)
  • [27] Whole-body FDG PET-MR oncologic imaging: pitfalls in clinical interpretation related to inaccurate MR-based attenuation correction
    Ulrike Attenberger
    Ciprian Catana
    Hersh Chandarana
    Onofrio A Catalano
    Kent Friedman
    Stefan A Schonberg
    James Thrall
    Marco Salvatore
    Bruce R. Rosen
    Alexander R. Guimaraes
    Abdominal Imaging, 2015, 40 : 1374 - 1386
  • [28] Whole-body FDG PET-MR oncologic imaging: pitfalls in clinical interpretation related to inaccurate MR-based attenuation correction
    Attenberger, Ulrike
    Catana, Ciprian
    Chandarana, Hersh
    Catalano, Onofrio A.
    Friedman, Kent
    Schonberg, Stefan A.
    Thrall, James
    Salvatore, Marco
    Rosen, Bruce R.
    Guimaraes, Alexander R.
    ABDOMINAL IMAGING, 2015, 40 (06): : 1374 - 1386
  • [29] Imaging features of ocular adnexal lymphoma: FDG-PET versus MR imaging.
    Hayasaka, K.
    Koyama, M.
    Yamashita, T.
    Nihashi, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S347 - S347
  • [30] Clinical applications of hybrid PET-MR
    Ratib, O.
    Lord, M.
    Becker, M.
    Viallon, M.
    Vallee, J. -P.
    Loubeyre, P.
    Willi, J. -P.
    Rager, O.
    Garibotto, V.
    Zaidi, H.
    Fleury, E.
    Figueiral, A.
    Becker, C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (10): : 605 - 614